Gynecologic Oncology Group
Roswell Park Cancer Institute
Elm & Carlton Streets
Buffalo
New York
14263-0001
United States
Tel: 716-845-5702
Fax: 716-845-8393
Website: http://www.gog.org/
Email: support@gogstats.org
5 articles with Gynecologic Oncology Group
-
It earned the FDA's green light after its Phase II innovaTV 204 clinical trial delivered stellar results in terms of tumor response and durability of the response.
-
Gynecologic Oncology Group Commences Enrollment In Stage 2 Of GOG-0265 Clinical Trial
3/11/2015
-
Gynecologic Oncology Group Phase 2 Study Of Advaxis, Inc.'s Lm-LLO Immunotherapy, ADXS-HPV, For The Treatment Of Persistent Or Recurrent Cervical Cancer Achieves Safety And Efficacy Criteria
1/28/2015
-
Gynecologic Oncology Group and Advaxis, Inc. Release: Dosing Begins for GOG US Cervical Cancer Study Evaluating ADXS-HPV
1/11/2012
-
Advaxis, Inc. to Host Dinner Reception For Members of the Gynecologic Oncology Group
1/23/2008